Sorry for interrupting, but there is something we need to tell you...

We have updated our Cookie Policy to reflect changes in the law on cookies used on websites in Europe. This website uses cookies to maximize your experience and help us to understand how we can improve it. To find out more click here.

Cookies are text files containing small amounts of data which are downloaded to your computer, or other device, when you visit a website. Cookies allow us to recognize your computer and improve your experience on our website. Some cookies are also necessary for the technical operation of our website. Please read our Cookie Policy which provides important information about the cookies we use, how we use them and how they can be deleted. Please remember that deleting cookies may affect your experience of our website.

Show less.

Accept and hide this message
Pillsbury Pillsbury Pillsbury
Email Page Print Friendly Version Text Size Subscribe


    Raj S. Davé, D.Sc.

    Raj S. Davé, D.Sc.

    T: +1.703.770.7782 F: +1.703.770.7901
    Email  |  Download vCard  | 

    Raj Davé is a partner in the law firm's Intellectual Property practice and is located in the Northern Virginia office. He focuses on strategic intellectual property counseling, patent prosecution, dispute resolution, licensing, technology transactions, intellectual property mining and enforcement, reexamination and reissue practice, pre-litigation opinions and patent litigation.

    He is the co-leader of Global Pharma and has assembled a highly experienced team of experts from a cross-section of key practice areas, including health care, intellectual property, litigation involving abbreviated new drug application (ANDA) and Paragraph IV suits, FDA/regulatory, as well as antitrust, advertising, corporate & securities, corporate investigations, crisis management, employment law, executive compensation and benefits, export controls, finance, global sourcing, foreign corrupt practice act (FCPA), life sciences, public policy, tax, technology transactions, and trade secrets. The global generic pharmaceuticals market presents many opportunities for our clients through Pillsbury, which has formed strategic alliances with major investment groups to finance ANDA litigations of generic pharmaceuticals.

    He represents U.S. and foreign clients in the areas of chemistry, biotechnology, physical science, materials and polymer science, life science, nanotechnology and electronics, in matters relating to biochips, bioinformatics, biophysics, biomedical, business method, combinatorial chemistry, composites and polymers, digital health, fuel cell, holographic and magnetic media, information technology, internet and software, lasers, medical devices, micro-electro-mechanical system (MEMS), optics, pharmaceuticals, telecommunications and wireless devices. Dr. Davé's experience includes counseling relating to ANDA challenges and generic drug litigation.

    His clients include major corporations that are world leaders in technological innovation, including several Fortune 100 companies. He has extensive experience managing large patent portfolios in several diversified technologies, including business method, hardware, and software technologies. In addition, he has carried out extensive due diligence analysis on patents on gaming and financial transactions.

    Prior to joining Pillsbury, Dr. Davé was a partner at Morrison & Foerster, and served as co-head of the Nanotech & Materials group at Morrison & Foerster.

    Dr. Davé is the Manager of the India Project of the George Washington University School of Law, where he is responsible for organizing an annual delegation of intellectual property judges and lawyers to India. He is on the Board of Invent Now Inc., an initiative of the National Inventors Hall of Fame Foundation.

    Dr. Davé is the recipient of several technical and legal writing awards. He has made over 25 technical presentations and over 30 legal presentations at conferences and symposia in the U.S., India, China, Japan and the UK. Dr. Davé is the author or co-author of more than 30 scientific publications in the area of polymers and composite materials, and numerous legal publications. Dr. Davé is the co-editor of a book entitled Processing of Composites.

    Honors & Awards
    • Legal 500 US, Patent Prosecution (2011-2013)
    • Pride of India Gold Award, Non-Resident Indian Institute of India (2006)
    • Burton Award for Legal Achievement (2004)
    • Managing Intellectual Property, IP Stars (2013-2014)
    • Robert C. Watson Award of the American Intellectual Property Law Association (2003)
    • Judge John R. Brown Award for Excellence in Legal Writing (2003)
    • Finnegan Prize of The George Washington University Law School, First Place (2003)
    • Nathan Burkan Memorial Competition, American Society of Composers, Authors and Publishers (ASCAP), National Prize (1997)
    • American Chemical Society, Student Paper Award (1986)
    • Society for the Advancement of Material and Process Engineering, Student Paper Award (1985)

    India Project of the George Washington University School of Law (Founder and Manager)

    Intellectual Property Owners Association—Asia Practice Committee (Past Vice Chair)

    American Intellectual Property Law Association—Programs Committee (Past Member)

    Inventors Hall of Fame—Invent Now Kids (Board Member)

    India-US World Affairs Institute (Chairman)

    Alumni Association of Indian Institute of Technology (PanIIT), DC Chapter (Founder and Board Member)

    Notable Presentations

    IP Licensing in Nanotechnology, AIPLA 2012 Annual Meeting, October 2012

    Managing Intellectual Property Portfolio in the U.S. and India, 3rd Summit for US-India Trade & Economics (SUITE), May 2012

    Managing Your Intellectual Property Portfolio in the U.S. and India, USINDIA Business Council (USIBC), April 2009

    Intellectual Property in India, 2008 NYIPLA Annual Conference, January 2008

    Inherent Anticipation: Lingering "Side Effects" on the Pharmaceutical Industry, 2007 AIPLA Annual Conference, October 2007

    Declaratory Judgment Standard Post-MedImmume, 2007 AIPLA Annual Conference, October 2007

    Compulsory Licensing in the United States, China, Japan, Germany and India, 1st IPO-JOP Asian Practice International Congress, September 2005

    Unforeseeability - The Touchstone of the Doctrine of Equivalents in the United States, 2004 AIPLA Annual Conference, October 2004

    District of Columbia, State of Connecticut
    Registered to practice before: U.S. Patent and Trademark Office
    Commonwealth of Virginia
    J.D., University of Connecticut School of Law, 1996
    LL.M., Patent Law, The George Washington University Law School, 2003
    D.Sc., Chemical Engineering/Materials Science, Washington University in St. Louis, 1986
    M.S., Materials & Polymer Science, Washington State University, 1983
    B.S., Chemical Engineering, Indian Institute of Technology, 1981

    Pillsbury Pillsbury Pillsbury